UK Voluntary Pricing Deal: Commercial Framework To Better Align With New Regulatory Pathways

 
• By Francesca Bruce

NHS England has committed to two pilots on innovative pricing models for advanced therapies under the UK’s new voluntary pricing agreement for new medicines.

gene therapy
VPAG Features Commitment To Outcomes-based Deal Pilots For ATMPs • Source: Shutterstock

More from Europe

More from Geography